testo-alternativo
Pediatric Imaging, Obesity Impacts, and Medication Safety

Pediatric Frontiers: Weekly Insights

Pediatria

Pediatric Imaging, Obesity Impacts, and Medication Safety

This episode covers recent pediatric research including COVID-19 imaging differences, obesity's impact on lung function, chronic kidney disease management, medication safety protocols, and regional metabolic research trends.

Accedi o Registrati per ascoltare questo episodio

Bibliografia

1. CT presentations of adult and pediatric SARS-CoV-2 patients: A review of early COVID-19 data.
Authors: Waller JV, Lin KK, Diaz MJ, et al.
Journal: Radiologia
PMID: 34801182
DOI: 10.1016/j.rxeng.2021.04.004


2. Effects of obesity on lung volume and capacity in children and adolescents: a systematic review.
Authors: Winck AD, Heinzmann-Filho JP, Soares RB, et al.
Journal: Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
PMID: 27130483
DOI: 10.1016/j.rpped.2016.02.008


3. Diagnostic approach and monitoring of chronic kidney disease in the primary care pediatric population.
Authors: Carrascal MI, Sánchez-Acosta KJ, Parra LJH, et al.
Journal: Boletin medico del Hospital Infantil de Mexico
PMID: 38941646
DOI: 10.24875/BMHIM.23000174


4. Metabolic and infectious pathologies in Brazilian medical literature: a review.
Authors: Rocha-e-Silva M
Journal: Clinics (Sao Paulo, Brazil)
PMID: 20835560
DOI: 10.1590/s1807-59322010000800012


5. Recommendations for the safe use of high-risk medications in pediatrics.
Authors: Otero MJ, Marrodan BR, Santos NP, et al.
Journal: Anales de pediatria
PMID: 40685171
DOI: 10.1016/j.anpede.2025.503815

Commenti

Per favore Accedi per lasciare un commento.

Ancora nessun commento.